Brilliant Violet 421(TM) anti-human CD335 (NKp46) 331914 from BioLegend

Product Specs
ItemBrilliant Violet 421(TM) anti-human CD335 (NKp46)
CompanyBioLegend
Price Pricing Info Supplier Page View Company Product Page
Catalog Number331914
Quantity100 tests
ApplicationsFlow Cytometry (FC)
Conjugate/TagBrilliant Violet 421™
FormatPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
ReactivityHuman
IsotypeIgG1, Kappa
Clone9E2
HostMouse
Antibody TypePrimary
ImmunogenNKp46-Fc fusion protein
NCBI Full Gene Namenatural cytotoxicity triggering receptor 1
NCBI Gene AliasesCD335, LY94, NK-p46, NKP46
ClonalityMonoclonal
TargetCD335

Add to Compare List

BioLegend

8999 BioLegend Way

San Diego, California 92121

United States

Phone: 1-877-246-5343 Toll-Free, USA & Canada
1-858-768-5800 International
Fax: 1-877-455-9587

Company Profile

Website: biolegend.com

(1) KLRC1 knockout overcomes HLA-E-mediated inhibition and improves NK cell antitumor activity against solid tumorsFrontiers in ImmunologyAugust 21, 2023Alice Mac Donald, Delphine Guipouy, William Lemieux, Mario Harvey, Louis-Jean Bordeleau, David Guay, Hugo Roméro, Yuanyi Li, Renaud Dion, Kathie Béland, et al.306411), PD-1-BV421 (BioLegend, 329919), CXCR2-BV421 (BD Biosciences, 744195), NKp46-BV421 (BioLegend, 331913), NKp30-BV785 (BioLegend, 325229), CD57-BV785 (BioLegend, 393329), CX3CR1-BV785 (BioLegend, 341627),

(2) Improving NK cell function in multiple myeloma with NKTR-255, a novel polymer-conjugated human IL-15Blood advancesJanuary 10, 2023Fernandez RA, Mayoral JE, Pierre-Louis L, Yao Y, Xu Y, Mu S, Martinez-Lopez J, Primo D, Miyazaki T, Prabhala R, et al.(Biolegend, Cat.#320821), anti-NKp30-PE (Biolegend, Cat.#325207), anti-NKp46-BV421 (Biolegend, Cat.#331914), anti-DNAM1-APC (Biolegend, Cat.#338311), anti-LAG3-FITC (Invitrogen [Waltham, MA], Cat.#11-2239-42),

(3) Activation of ADAM17 by IL-15 Limits Human NK Cell ProliferationFrontiers in ImmunologyJuly 22, 2021Hemant K. Mishra, Kate J. Dixon, Nabendu Pore, Martin Felices, Jeffrey S. Miller, Bruce WalcheckCA" CD3,HIT3a,300440,BioLegend CD16,3G8,302038,BioLegend CD336/NKp44,P44-8,325108,BioLegend CD335/NKp46,9E2,331914,BioLegend CD159a/NKG2A,Z199,A60797,"Beckman Coulter, Brea, CA" CD314/NKG2D,1D11,320806,BioLegend CD158a/KIR2DL1,HP-MA4,339504,BioLegend CD158b1/KIR2DL2/L3,DX27,312612,BioLegend CD158e1/KIR3DL1,DX9,312714,BioLegend CD45,HI30,304044,BioLegend CD62L/L-selectin,DREG56,304810,Biolegend CD62L/L-selectin,DREG200,HB302,"ATCC,

(4) A population of CD4 ^hi CD38 ^hi T cells correlates with disease severity in patients with acute malariaClinical & Translational ImmunologyNovember 24, 2020Simon H Apte et al.

(5) TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancerOncoimmunologyNovember 8, 2020Maas RJ, Hoogstad-van Evert JS, Van der Meer JM, Mekers V, Rezaeifard S, Korman AJ, de Jonge PK, Cany J, Woestenenk R, Schaap NP, et al.R&D Systems, #FAB138P), NKG2D PE-Cy7 (clone 1D11, Biolegend, 320812), NKp46 BV421 (clone 9E2, Biolegend, #331914), NKG2a APC (clone Z199, Beckman Coulter, #A60797), PD-1 BV421 (clone EH12.1, BD Bioscience, #562516),

(6) Tissue-resident Eomes⁺ NK cells are the major innate lymphoid cell population in human infant intestineNature communicationsFebruary 28, 2019Sagebiel AF, Steinert F, Lunemann S, Körner C, Schreurs RRCE, Altfeld M, Perez D, Reinshagen K, Bunders MJ.310944, 1:80), CD69-BV605 (FN50, 310938, 1:50), CD69-BV421 (FN50, 310930, 1:200), NKp46/CD335-BV421 (9E2, 331913, 1:40), NKp44/CD336-PE (P44-8, 352107, 1:40), CXCR6/CD186-PE-Cy7 (K041E5, 356012, 1:20), CD107a-BV421

(7) Antigen-Specific CD8 Lytic Phenotype Induced by Sipuleucel-T in Hormone-Sensitive or Castration-Resistant Prostate Cancer and Association with Overall SurvivalClinical cancer research : an official journal of the American Association for Cancer ResearchOctober 1, 2018Antonarakis ES, Small EJ, Petrylak DP, Quinn DI, Kibel AS, Chang NN, Dearstyne E, Harmon M, Campogan D, Haynes H, et al.#302234), CD14 BV421 (BD Biosciences; clone MoP9, #56743), and CD335 BV421 (BioLegend; clone 29A1.4, #331914). A minimum of 100,000 events were collected and analyzed for CD4+ and CD8+ T-cell proliferation or

(8) CLEC10A Is a Specific Marker for Human CD1c⁺ Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine SecretionFrontiers in immunologyJanuary 1, 2018Heger L, Balk S, Lühr JJ, Heidkamp GF, Lehmann CHK, Hatscher L, Purbojo A, Hartmann A, Garcia-Martin F, Nishimura SI, et al.

(9) Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden populationPloS oneJanuary 1, 2017Baguma R, Penn-Nicholson A, Smit E, Erasmus M, Day J, Makhethe L, de Kock M, Hughes EJ, van Rooyen M, Pienaar B, et al.(506804), anti-IL-6-APC (501112), antiCD3-BV421 (300434), anti-CD19-BV421 (302233) and anti-CD335-BV421 (331913) all from Biolegend. Cryopreserved, fixed white cells were washed in PBS and stained for 1 hour at 4˚C

(10) Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cellsJournal of immunology (Baltimore, Md. : 1950)March 15, 2015Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson MA, Kekäläinen E, Johansson H, Mjösberg J, Westgren M, Lankisch TO, et al.

(11) Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrowThe Journal of experimental medicineMarch 9, 2015Lee J, Breton G, Oliveira TY, Zhou YJ, Aljoufi A, Puhr S, Cameron MJ, Sékaly RP, Nussenzweig MC, Liu K.

(12) Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cellsBloodJuly 28, 2011Correia DV, Fogli M, Hudspeth K, da Silva MG, Mavilio D, Silva-Santos B.

(13) Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidaseJournal of virologyAugust 1, 2009Jarahian M, Watzl C, Fournier P, Arnold A, Djandji D, Zahedi S, Cerwenka A, Paschen A, Schirrmacher V, Momburg F.

(14) Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donorThe New England journal of medicineDecember 15, 1977R J O'Reilly, B Dupont, S Pahwa, E Grimes, E M Smithwick, R Pahwa, S Schwartz, J A Hansen, F P Siegal, M Sorell, A Svejgaard, C Jersild, M Thomsen, P Platz, P L'Esperance, R A Good

Be the First to Write a Review!

Nature communications

Brilliant Violet 421(TM) anti-human CD335 (NKp46) from BioLegend

Description

BioLegend

Citations (14)

Reviews

Brilliant Violet 421(TM) anti-human CD335 (NKp46) from BioLegend

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map